Works matching IS 13520504 AND DT 2012 AND VI 19 AND IP 8

Results: 9

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 537, doi. 10.1111/j.1365-2893.2011.01579.x
By:
- Manns, M. P.;
- Wedemeyer, H.;
- Singer, A.;
- Khomutjanskaja, N.;
- Dienes, H. P.;
- Roskams, T.;
- Goldin, R.;
- Hehnke, U.;
- Inoue, H.
Publication type:
Article
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 568, doi. 10.1111/j.1365-2893.2011.01578.x
By:
- Girardin, F.;
- Daali, Y.;
- Gex-Fabry, M.;
- Rebsamen, M.;
- Roux-Lombard, P.;
- Cerny, A.;
- Bihl, F.;
- Binek, J.;
- Moradpour, D.;
- Negro, F.;
- Desmeules, J.
Publication type:
Article
A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 581, doi. 10.1111/j.1365-2893.2012.01589.x
By:
- Yang, F.-Q.;
- Yu, Y.-Y.;
- Wang, G.-Q.;
- Chen, J.;
- Li, J.-H.;
- Li, Y.-Q.;
- Rao, G.-R.;
- Mo, G.-Y.;
- Luo, X.-R.;
- Chen, G.-M.
Publication type:
Article
Hepatitis C virus-specific immune responses in noninjecting drug users.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 554, doi. 10.1111/j.1365-2893.2011.01573.x
By:
- Zeremski, M.;
- Makeyeva, J.;
- Arasteh, K.;
- Des Jarlais, D. C.;
- Talal, A. H.
Publication type:
Article
Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 594, doi. 10.1111/j.1365-2893.2011.01577.x
By:
- Sarkar, M.;
- Stewart, S.;
- Yu, A.;
- Chen, M. S.;
- Nguyen, T. T.;
- Khalili, M.
Publication type:
Article
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 547, doi. 10.1111/j.1365-2893.2011.01572.x
By:
- Biermer, M.;
- Schlosser, B.;
- Fülöp, B.;
- van Bömmel, F.;
- Brodzinski, A.;
- Heyne, R.;
- Keller, K.;
- Sarrazin, C.;
- Berg, T.
Publication type:
Article
Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 574, doi. 10.1111/j.1365-2893.2012.01583.x
By:
- Chen, W.;
- Tomlinson, G.;
- Krahn, M.;
- Heathcote, J.
Publication type:
Article
HCV burden of infection in Egypt: results from a nationwide survey.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 560, doi. 10.1111/j.1365-2893.2011.01576.x
By:
- Guerra, J.;
- Garenne, M.;
- Mohamed, M. K.;
- Fontanet, A.
Publication type:
Article
Hepatitis C therapy in non-genotype 1 patients: the near future.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 8, p. 525, doi. 10.1111/j.1365-2893.2012.01634.x
By:
- Wartelle-Bladou, C.;
- Le Folgoc, G.;
- Bourlière, M.;
- Lecomte, L.
Publication type:
Article